UK scientists bring innovative vaccine technology to Vietnam3 December 2019World-leading vaccine scientists from the University of Bristol are working with one of Vietnam's major vaccine manufacturers, Vabiotech, to share cutting-edge knowledge that could help prevent future global outbreaks of avian flu and rabies.
Scientists discover body’s protection shield18 November 2019Scientists have discovered a way to manipulate the body’s own immune response to help boost tissue repair. The findings, published in Current Biology today [18 Nov], reveal a new network of protective factors to shield cells against damage. This discovery, made by University of Bristol researchers, could significantly benefit patients undergoing surgery by speeding recovery times and lowering the risk of complication.
University of Bristol spin-out raises £760,000 to commercialise biosensing technology31 October 2019Rosa Biotech, a new University of Bristol spin-out which developed a sensing platform capable of detecting the faint chemical signature given off by chronic diseases has raised £760,000 to commercialise its ground-breaking innovation. The artificial Intelligence (AI)-driven biosensing technology, which mimics mammals’ sense of smell, has significant potential to transform the medical diagnostics and pharmaceuticals industries.
£18.5 million boost for South West biosciences24 October 2019PhD training across the biosciences has received a massive boost thanks to a £18.5 million funding award from the Biotechnology and Biological Sciences Research Council (BBSRC, part of UK Research and Innovation) to the University of Bristol-led South West Biosciences Doctoral Training Partnership (SWBio DTP).
Scientists join forces to shed new light on ageing and wound healing9 October 2019Researchers from the Universities of Manchester and Bristol have been granted £4m to investigate how cells govern the processes of ageing and wound healing and how this is influenced by the circadian (day/night) cycle. Their findings could help to improve wound healing and identify strategies to treat diseases like osteoarthritis.
Pets as Therapy session30 September 2019"It was an amazing start to the day. I think we should do it more frequently, as it could genuinely help our wellbeing."
Powerful new synthetic vaccines to combat epidemics26 September 2019A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings, published in Science Advances today [Wednesday 25 September], reveal exceptionally promising results for the Chikungunya vaccine candidate, which has been engineered using a synthetic protein scaffold that could revolutionise the way vaccines are designed, produced and stored.
Putting the squeeze on red blood cells11 September 2019For the first time, researchers at the University of Bristol’s Blood and Transplant Research Unit, and the French National Institute for Blood Transfusion, have captured the moment a red blood cell is ‘squeezed’ while recording the changes that allow it to deform and subsequently recover its shape.
A different kind of BioDesign9 September 2019One of our postgraduate researchers, Claire Noble, designed a mural that decorates the wall of the Robin Hood pub. Claire writes about her experience and thoughts behind the design.
Biochemistry Good Citizen Award 20192 August 2019Upon his formal retirement after 45 years as a member of the School of Biochemistry, Professor Andrew Halestrap provided the funds to enable an annual award to be made to a Biochemistry final year student who has demonstrated exceptional good citizenship. Nominations are received from members of both academic staff and students.
Zebrafish capture a 'window' on the cancer process4 June 2019Cancer-related inflammation impacts significantly on cancer development and progression. New research has observed in zebrafish, for the first time, that inflammatory cells use weak spots or micro-perforations in the extracellular matrix barrier layer to access skin cancer cells.
New Max Planck-Bristol Centre for Minimal Biology launched27 March 2019Building stripped-down versions of life using protocells, genome delivery systems and synthetic cytoskeletons comprise some of the groundbreaking research due to take place at a new Centre launched at the University of Bristol today [Wednesday 27 March]. The Max Planck-Bristol Centre for Minimal Biology, a partnership between the University of Bristol and the Max Planck Society for the Advancement of Science (MPG) in Germany, aims to advance the future of health and medicine by understanding the fundamental nature of life.